Article History
Received: 13 September 2019
Accepted: 3 October 2019
First Online: 6 November 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: KR has received research funding from AbbVie and Pfizer and honoraria/consultancy fees from AbbVie, Sanofi, Lilly, Bristol-Myers Squibb, UCB, Pfizer, Janssen and Roche Chugai.